Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Brazil to import 2 million AstraZeneca vaccine doses, not yet approved for use

FILE PHOTO: Dose of the Oxford University/AstraZeneca COVID-19 vaccine is displayed at the Princess Royal Hospital in Haywards Heath, West Sussex, Britain January 2, 2021. Picture taken January 2, 2021. Gareth Fuller/PA Wire/Pool via REUTERS/File Photo

Brazil's health regulator Anvisa said late on Saturday it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.

Anvisa said it approved the importation request from federal government-affiliated biomedical center Fiocruz on Thursday.

Importing the doses prior to approval will enable vaccination to begin as soon as Anvisa okays its use, the regulator said. Brazil has yet to approve any vaccine.

Fiocruz will apply for emergency use of the vaccine by Wednesday, its president, Nísia Trindade, said last week.

Brazil has recorded the second-deadliest outbreak of COVID-19 after only the United States. South America's largest country has the third highest tally of coronavirus cases, with the health ministry registering more than 7.7 million, after the United States and India.

(Reporting by Jake Spring; Editing by Daniel Wallis)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.